drugset / Trial / NCT03508804

Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion

NCT03508804

Phase 3 Withdrawn Stanford University
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators theorize that the application of a lidocaine-prilocaine cream 5-10 minutes prior to the administration of a paracervical block could decrease pain associated with its administration and pain with abortion overall.

Timeline

Start
2020-12
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 % Intravenous
Subject Lidocaine Other / unclassified 2.5 % Intravenous
Subject Lidocaine Other / unclassified 10 ml Intravenous
Subject prilocaine Small molecule 2.5 % Intravenous
Subject prilocaine Small molecule 10 ml Intravenous

Indications

No indication recorded.